APA-referens

Lalić, N., Russel-Szymczyk, M., Culic, M., Tikkanen, C. K., & Chubb, B. (2018). Cost-Effectiveness of Insulin Degludec Versus Insulin Glargine U100 in Patients with Type 1 and Type 2 Diabetes Mellitus in Serbia. Diabetes Ther.

Chicago-stil citat

Lalić, Nebojša, Monika Russel-Szymczyk, Marina Culic, Christian Klyver Tikkanen, och Barrie Chubb. "Cost-Effectiveness of Insulin Degludec Versus Insulin Glargine U100 in Patients With Type 1 and Type 2 Diabetes Mellitus in Serbia." Diabetes Ther 2018.

MLA-referens

Lalić, Nebojša, et al. "Cost-Effectiveness of Insulin Degludec Versus Insulin Glargine U100 in Patients With Type 1 and Type 2 Diabetes Mellitus in Serbia." Diabetes Ther 2018.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.